Highline Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$508K Buy
1,917
+282
+17% +$74.4K 0.1% 81
2026
Q2
$415K Buy
1,635
+974
+147% +$227K 0.08% 79
2026
Q1
$162K Buy
661
+56
+9% +$13K 0.04% 96
2025
Q4
$125K Buy
605
+164
+37% +$32.4K 0.04% 81
2025
Q3
$81.8K Buy
441
+164
+59% +$28.1K 0.02% 132
2025
Q2
$42.3K Buy
277
+25
+10% +$3.84K 0.01% 153
2025
Q1
$41.9K Buy
252
+86
+52% +$13.5K 0.01% 143
2024
Q4
$24K Sell
166
-27
-14% -$4.18K 0.01% 170
2024
Q3
$31.2K Buy
193
+11
+6% +$1.75K 0.01% 153
2024
Q2
$26.6K Buy
182
+79
+77% +$11.7K 0.01% 158
2024
Q1
$16.3K Sell
103
-56
-35% -$8.91K 0.01% 184
2023
Q4
$24.9K Sell
159
-60
-27% -$9.2K 0.01% 147
2023
Q3
$34.1K Hold
219
– – 0.02% 126
2023
Q2
$36.2K Buy
219
+29
+15% +$4.68K 0.02% 116
2023
Q1
$29.5K Sell
190
-112
-37% -$18.1K 0.02% 117
2022
Q4
$53.3K Buy
302
+79
+35% +$13.6K 0.04% 109
2022
Q3
$36.4K Buy
+223
New +$37.7K 0.03% 99

Other funds holding JNJ

Highline Wealth Partners's JNJ Position: Q3 2026 in Review

Highline Wealth Partners increased its Johnson & Johnson (JNJ) stake by 17% in Q3 2026, buying an estimated $74.4K and bringing the position to 1,917 shares worth $508K. The position accounts for 0.1% of the portfolio, ranked #81.

Highline Wealth Partners first reported a position in JNJ in Q3 2022 and has held it in 17 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Highline Wealth Partners held 1,917 shares of Johnson & Johnson worth $508K as of Q3 2026.
  • Highline Wealth Partners bought 282 Johnson & Johnson shares in Q3 2026, an estimated $74.4K.
  • Johnson & Johnson made up 0.1% of Highline Wealth Partners's portfolio in Q3 2026, its #81 holding.
  • Highline Wealth Partners first reported a position in Johnson & Johnson in Q3 2022 and has held it in 17 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.